Riociguat | All | Licensing, EU CTD Dossiers, Formulation Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Riociguat
FDF Dossiers

PharmaCompass Sponsored Ads

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-1-m-2026-04-20

PharmaCompass Sponsored Ads

Contact Supplier

Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Contact Supplier

pharmacompass-2-m-2026-04-20

Riociguat

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 6 USDMF, 3 CEP/COS, 2 EU WC, 2 NDC API, 15 Listed Suppliers

18 API Suppliers
6 USDMF
3 CEP/COS
2 EU WC
2 NDC API
15 Listed Suppliers

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

FINISHED DOSAGE FORMULATIONS

98 FDF Dossiers, 14 FDA Orange Book, 54 Europe, 10 Canada, 20 Australia

98 FDF Dossiers
14 FDA Orange Book
54 Europe
10 Canada
20 Australia

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 4 Ideal Cures, 19 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 16 Granulation, 15 Controlled & Modified Release, 14 Direct Compression, 11 Thickeners and Stabilizers, 11 Lubricants & Glidants, 9 Co-Processed Excipients, 8 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 5 Disintegrants & Superdisintegrants, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Emulsifying Agents, 4 Topical, 3 API Stability Enhancers, 3 Solubilizers, 2 Rheology Modifiers, 2 Parenteral, 2 Coloring Agents, 1 Surfactant & Foaming Agents

39 Coating Systems & Additives
30 Fillers, Diluents & Binders
16 Granulation
15 Controlled & Modified Release
14 Direct Compression
11 Thickeners and Stabilizers
11 Lubricants & Glidants
9 Co-Processed Excipients
8 Film Formers & Plasticizers
6 Taste Masking
5 Empty Capsules
5 Disintegrants & Superdisintegrants
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 Emulsifying Agents
4 Topical
3 API Stability Enhancers
3 Solubilizers
2 Rheology Modifiers
2 Parenteral
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

1 Data Compilation #PharmaFlow
24 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Regulatory FDF Prices, 19 Annual Reports

1 US Medicaid Prescriptions
9 Regulatory FDF Prices
19 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

35 US Patents, 10 Health Canada Patents

35 US Patents
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

98 All

01 5Abacus Medicine

02 79Bayer AG

03 5MSN Laboratories

04 5Sandoz B2B

05 4Teva Pharmaceutical Industries

filter Dosage Reset all filters

98 All

01 38Film Coated Tablet

02 5Film-Coated Tablet

03 2Granule For Oral Suspension

04 1Riociguat 0.5Mg 42 Combined Oral Use

05 1Riociguat 1,5Mg 42 Combined Oral Use

06 1Riociguat 1,5Mg 84 Combined Oral Use

07 1Riociguat 1Mg 42 Combined Oral Use

08 1Riociguat 1Mg 84 Combined Oral Use

09 1Riociguat 2,5Mg 42 Combined Oral Use

10 1Riociguat 2,5Mg 84 Combined Oral Use

11 1Riociguat 2Mg 42 Combined Oral Use

12 1Riociguat 2Mg 84 Combined Oral Use

13 10TABLET

14 14TABLET;ORAL

15 20Blank

filter Regulatory Info Reset all filters

98 All

01 5Allowed

02 6Approved

03 9Authorized

04 13Marketed

05 1Not Marketed

06 10PRESCRIPTION

07 11Prescription

08 10RX

09 33Blank

filter Brand Name Reset all filters

98 All

01 10ADEMPAS

02 74Adempas

03 9RIOCIGUAT

04 5SANDOZ RIOCIGUAT

filter Country Reset all filters

98 All

01 20Australia

02 10Canada

03 5Denmark

04 6Estonia

05 9Italy

06 14Norway

07 9Spain

08 6Sweden

09 5Switzerland

10 14USA

List of Suppliers

Product Main Page

01

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : ADEMPAS

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2013-10-08

Application Number : 204819

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : ADEMPAS

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2013-10-08

Application Number : 204819

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : ADEMPAS

Dosage Form : TABLET;ORAL

Dosage Strength : 1.5MG

Packaging :

Approval Date : 2013-10-08

Application Number : 204819

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : ADEMPAS

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2013-10-08

Application Number : 204819

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : ADEMPAS

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG

Packaging :

Approval Date : 2013-10-08

Application Number : 204819

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Adempas

Dosage Form : Riociguat 0.5Mg 42 Combined Oral Use

Dosage Strength : 42 cpr riv 0.5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Adempas

Dosage Form : Riociguat 1Mg 42 Combined Oral Use

Dosage Strength : 42 cpr riv 1 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Adempas

Dosage Form : Riociguat 1Mg 84 Combined Oral Use

Dosage Strength : 84 cpr riv 1 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Adempas

Dosage Form : Riociguat 1,5Mg 42 Combined Oral Use

Dosage Strength : 42 cpr riv 1.5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Adempas

Dosage Form : Riociguat 1,5Mg 84 Combined Oral Use

Dosage Strength : 84 cpr riv 1.5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

11

Bayer AG

BPI Europe

Not Confirmed

Bayer AG

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Adempas

Dosage Form : Riociguat 2Mg 42 Combined Oral Use

Dosage Strength : 42 cpr riv 2 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

12

MSN Laboratories

BPI Europe

Not Confirmed

MSN Laboratories

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2022-09-01

Application Number : 211135

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

13

MSN Laboratories

BPI Europe

Not Confirmed

MSN Laboratories

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2022-09-01

Application Number : 211135

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

14

MSN Laboratories

BPI Europe

Not Confirmed

MSN Laboratories

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 1.5MG

Packaging :

Approval Date : 2022-09-01

Application Number : 211135

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

15

MSN Laboratories

BPI Europe

Not Confirmed

MSN Laboratories

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2022-09-01

Application Number : 211135

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

16

MSN Laboratories

BPI Europe

Not Confirmed

MSN Laboratories

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG

Packaging :

Approval Date : 2022-09-01

Application Number : 211135

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

17

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 211044

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

18

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 1.5MG

Packaging :

Approval Date :

Application Number : 211044

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

19

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number : 211044

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

20

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Teva Pharmaceutical Industries

BPI Europe

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

Brand Name : RIOCIGUAT

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 211044

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.